Abstract

ObjectiveTo assess effects of maternal anemia on the impact of maternal multiple micronutrient (MMN) supplementation compared to iron & folic acid (IFA) in a double blind RCT in Indonesia (ISRCTN34151616).MethodsWe analyzed 14611 singleton births with data on maternal hemoglobin (Hb), height, parity, education, gestational age at birth, sex, season of birth & household wealth. Mortality was analyzed with Cox proportional hazards models; birth weight (BW) & maternal Hb with linear models; low birth weight (LBW), small for gestational age (SGA) & preterm‐LBW with logistic models.ResultsIn anemic women MMN reduced early infant mortality (< 90 days of birth) by 39% [Adj HR 0.61; 95%CI 0.49–0.78 p<0.001; interaction (int) p=0.04] and neonatal mortality by 36% (Adj HR 0.64; CI=0.47–0.86 p=0.003; int p=0.18). MMN improved BW by 37g (CI −1 to 74 p=0.056; int p=0.01), and reduced LBW by 17% (aRR 0.83; CI 0.66–1.05 p=0.11; int p=0.04) and preterm‐LBW by 40% (aRR 0.60; CI 0.42–0.87 p=0.007; int p=0.002), and improved Hb by 0.28g/dl (CI −0.031 to 0.59 p=0.08) in anemic women.ConclusionsMaternal MMN supplements, as compared to IFA, have greater benefits on infant survival and birth weight in anemic than in non‐anemic women.Funding:Turner Foundation, UNICEF, CHHD, USAID Indonesia grant # 497G00010000100. AusAID supported SKS's PhD at U of Sydney.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.